GB Patent

GB0123571D0 — Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis

Assigned to Aventis Pharmaceuticals Inc · Expires 2001-11-21 · 24y expired

What this patent protects

Patent listed against Aubagio.

Drugs covered by this patent

Patent Metadata

Patent number
GB0123571D0
Jurisdiction
GB
Classification
—
Expires
2001-11-21
Drug substance claim
No
Drug product claim
No
Assignee
Aventis Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.